164 related articles for article (PubMed ID: 35200654)
1. Sdy-1 Executes Antitumor Activity in HepG2 and HeLa Cancer Cells by Inhibiting the Wnt/β-Catenin Signaling Pathway.
Sun M; Zhou D; Wu J; Zhou J; Xu J
Mar Drugs; 2022 Feb; 20(2):. PubMed ID: 35200654
[TBL] [Abstract][Full Text] [Related]
2. Piplartine suppresses proliferation and invasion of hepatocellular carcinoma by LINC01391-modulated Wnt/β-catenin pathway inactivation through ICAT.
Fan X; Song J; Zhao Z; Chen M; Tu J; Lu C; Wu F; Zhang D; Weng Q; Zheng L; Xu M; Ji J
Cancer Lett; 2019 Sep; 460():119-127. PubMed ID: 31207322
[TBL] [Abstract][Full Text] [Related]
3. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
[TBL] [Abstract][Full Text] [Related]
4. H19-Wnt/β-catenin regulatory axis mediates the suppressive effects of apigenin on tumor growth in hepatocellular carcinoma.
Pan FF; Zheng YB; Shi CJ; Zhang FW; Zhang JF; Fu WM
Eur J Pharmacol; 2021 Feb; 893():173810. PubMed ID: 33345859
[TBL] [Abstract][Full Text] [Related]
5. Combretastatin A-1 phosphate, a microtubule inhibitor, acts on both hepatocellular carcinoma cells and tumor-associated macrophages by inhibiting the Wnt/β-catenin pathway.
Mao J; Wang D; Wang Z; Tian W; Li X; Duan J; Wang Y; Yang H; You L; Cheng Y; Bian J; Chen Z; Yang Y
Cancer Lett; 2016 Sep; 380(1):134-43. PubMed ID: 27349166
[TBL] [Abstract][Full Text] [Related]
6. Babao Dan is a robust anti-tumor agent via inhibiting wnt/β-catenin activation and cancer cell stemness.
Xie X; Chen J; Wo D; Ma E; Ning Y; Peng J; Zhu W; Ren DN
J Ethnopharmacol; 2021 Nov; 280():114449. PubMed ID: 34332067
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of Codonopsis pilosula in inhibiting hepatocellular carcinoma growth and metastasis.
Li N; Yang C; Xia J; Wang W; Xiong W
Phytomedicine; 2024 Jun; 128():155338. PubMed ID: 38520835
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of antibiotic drug tigecycline against cervical squamous cell carcinoma by inhibiting Wnt/β-catenin signaling.
Li H; Jiao S; Li X; Banu H; Hamal S; Wang X
Biochem Biophys Res Commun; 2015 Nov; 467(1):14-20. PubMed ID: 26427870
[TBL] [Abstract][Full Text] [Related]
9. Plumbagin inhibits proliferation and induces apoptosis of hepatocellular carcinoma by downregulating the expression of SIVA.
Li T; Lv M; Chen X; Yu Y; Zang G; Tang Z
Drug Des Devel Ther; 2019; 13():1289-1300. PubMed ID: 31118568
[No Abstract] [Full Text] [Related]
10. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
Ma L; Wang X; Jia T; Wei W; Chua MS; So S
Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic constituents from the mangrove endophytic Pestalotiopsis sp. induce G
Zhou J; Li G; Deng Q; Zheng D; Yang X; Xu J
Nat Prod Res; 2018 Dec; 32(24):2968-2972. PubMed ID: 29086604
[TBL] [Abstract][Full Text] [Related]
12. Effect of trichostatin A on anti HepG2 liver carcinoma cells: inhibition of HDAC activity and activation of Wnt/β-Catenin signaling.
Shi QQ; Zuo GW; Feng ZQ; Zhao LC; Luo L; You ZM; Li DY; Xia J; Li J; Chen DL
Asian Pac J Cancer Prev; 2014; 15(18):7849-55. PubMed ID: 25292076
[TBL] [Abstract][Full Text] [Related]
13. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway.
Cao F; Yin LX
Exp Mol Pathol; 2019 Feb; 106():34-43. PubMed ID: 30539797
[TBL] [Abstract][Full Text] [Related]
14. Urolithin B suppresses tumor growth in hepatocellular carcinoma through inducing the inactivation of Wnt/β-catenin signaling.
Lv MY; Shi CJ; Pan FF; Shao J; Feng L; Chen G; Ou C; Zhang JF; Fu WM
J Cell Biochem; 2019 Oct; 120(10):17273-17282. PubMed ID: 31218741
[TBL] [Abstract][Full Text] [Related]
15. C644-0303, a small-molecule inhibitor of the Wnt/β-catenin pathway, suppresses colorectal cancer growth.
Yan Y; Zhang Y; Li M; Zhang Y; Zhang X; Zhang X; Xu Y; Wei W; Wang J; Xu X; Song Q; Zhao C
Cancer Sci; 2021 Nov; 112(11):4722-4735. PubMed ID: 34431598
[TBL] [Abstract][Full Text] [Related]
16. Baohuoside-1 targeting mTOR inducing apoptsis to inhibit hepatocellular carcinoma proliferation, invasion and migration.
Guo Y; Zhu H; Weng M; Chen B; Wang C; Sun L
Biomed Pharmacother; 2020 Aug; 128():110366. PubMed ID: 32526459
[TBL] [Abstract][Full Text] [Related]
17. Thymol Isolated from
Zeng Q; Che Y; Zhang Y; Chen M; Guo Q; Zhang W
Drug Des Devel Ther; 2020; 14():2535-2547. PubMed ID: 32669835
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo anti-tumor activity of CoQ0 against melanoma cells: inhibition of metastasis and induction of cell-cycle arrest and apoptosis through modulation of Wnt/β-catenin signaling pathways.
Hseu YC; Thiyagarajan V; Tsou HT; Lin KY; Chen HJ; Lin CM; Liao JW; Yang HL
Oncotarget; 2016 Apr; 7(16):22409-26. PubMed ID: 26968952
[TBL] [Abstract][Full Text] [Related]
19. Chinese herbal formula QHF inhibits hepatocellular carcinoma metastasis via HGF/c-Met signaling pathway.
Yuan S; Gong Y; Chen R; Du J; Zhang H; Chen T
Biomed Pharmacother; 2020 Dec; 132():110867. PubMed ID: 33075668
[TBL] [Abstract][Full Text] [Related]
20. 1118-20, an indazole diarylurea compound, inhibits hepatocellular carcinoma HepG2 proliferation and tumour angiogenesis involving Wnt/β-catenin pathway and receptor tyrosine kinases.
Lu YY; Wang JJ; Zhang XK; Li WB; Guo XL
J Pharm Pharmacol; 2015 Oct; 67(10):1393-405. PubMed ID: 26076716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
